AXA S.A. - FREELINE THERAPEUTICS HLDGS ownership

FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 21 filers reported holding FREELINE THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
AXA S.A. ownership history of FREELINE THERAPEUTICS HLDGS
ValueSharesWeighting
Q4 2021$562,000
-70.9%
283,820
-49.9%
0.00%
-80.0%
Q3 2021$1,931,000
-78.7%
566,207
-49.1%
0.01%
-61.5%
Q2 2021$9,058,000
+32.5%
1,111,510
+100.0%
0.01%
-38.1%
Q1 2021$6,836,000
-32.1%
555,778
+0.8%
0.02%
-34.4%
Q4 2020$10,070,000
+17.5%
551,476
+0.4%
0.03%
+3.2%
Q3 2020$8,572,000549,1540.03%
Other shareholders
FREELINE THERAPEUTICS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
CHI Advisors LLC 1,361,064$24,853,0007.00%
Novo Holdings A/S 2,361,229$43,116,0001.85%
Ally Bridge Group (NY) LLC 425,000$7,761,0001.33%
TFG Asset Management GP Ltd 750,000$13,695,0000.92%
SECTORAL ASSET MANAGEMENT INC 657,494$12,006,0000.85%
FRAZIER MANAGEMENT LLC 550,000$10,043,0000.77%
Eventide Asset Management 2,485,656$44,266,0000.68%
Ovata Capital Management Ltd 14,981$274,0000.09%
AXA S.A. 551,476$10,070,0000.03%
Woodline Partners LP 25,932$474,0000.01%
View complete list of FREELINE THERAPEUTICS HLDGS shareholders